What Does Radiomics Do in PD-L1 Blockade Therapy of NSCLC Patients?

0
245
To explore the feasibility of the clinical application of radiomics in predicting PD-L1 expression, immunotherapy response, and long-term prognosis, the authors review and summarize recently published works in NSCLC.
[Thoracic Cancer]
Full Article